Skip to main content

Table 1 Socio-demographic and clinical characteristics of patients with advanced stage of CRC

From: Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis

 

AJCC Stage classification

 

Characteristics

Stage III (n = 115)

Stage IV (n = 45)

Total (n = 160)

P-value

Age (Year,median, interquartile range)

62 (54–71)

62 (55–74)

62 (54–72)

0.301

Sex (%)

   

0.536

  Male

56.5%

51.1%

55.0%

 

  Female

43.5%

48.9%

45.0%

 

Education level (%)

   

0.939

  No formal school

12.4%

11.1%

12.0%

 

  Primary

30.1%

26.7%

29.1%

 

  Secondary

43.4%

48.9%

44.9%

 

  Tertiary

14.2%

13.3%

13.9%

 

Marital status (%)

   

0.942

  Married

76.1%

75.6%

75.9%

 

  Not married

23.9%

24.4%

24.1%

 

Currently working (%)

   

0.002a

  Yes

29.2%

6.7%

22.8%

 

  No

70.8%

93.3%

77.2%

 

Income (%)

   

0.075

  ≤HKD$20,000

78.4%

90.7%

81.8%

 

  >HKD$20,000

21.6%

9.3%

18.2%

 

Smoking (%)

   

0.016a

  Ever had

17.7%

35.6%

22.8%

 

  Never had

82.3%

64.4%

77.2%

 

Drinking (%)

   

0.247

  Ever had

26.3%

35.6%

28.9%

 

  Never had

73.7%

64.4%

71.1%

 

Primary tumour site (%)

   

0.191

  Colon

53.0%

64.4%

56.3%

 

  Rectum

47.0%

35.6%

43.8%

 

Active CRC treatment (%)

   

<0.001a

  No

80.7%

35.6%

67.9%

 

  Yes

19.3%

64.4%

32.1%

 

Stoma (%)

   

0.112

  Present

10.5%

20.0%

13.2%

 

  Absent

89.5%

80.0%

86.8%

 

Time since diagnosis (month,median, interquartile range)

31 (13–59)

23 (11–52)

27 (12–58)

0.165

Vital status (%)

   

0.093

  Alive

93.0%

84.4%

90.6%

 

  Death

7.0%

15.6%

9.4%

 

  Follow-up Month for Alive (median, interquartile range)

23 (21–25)

24 (23–26)

23 (22–25)

0.088

  Follow-up Month for Death (median, interquartile range)

21 (18–24)

24 (18–26)

21 (18–25)

0.336

  Follow-up Month for Total (median, interquartile range)

23 (21–25)

24 (22–26)

23 (21–25)

0.750

CRC recurrenceb (%)

   

<0.001a

  Yes

10.2%

37.9%

16.1%

 

  No

89.8%

62.1%

83.9%

 
  1. Note: AJCC=American Joint Committee on Cancer.
  2. aSignificant differences (P<0.05) between groups by Mann-Whitney U-test or by Chi-square test, as appropriate.
  3. bExcluded 23 subjects who had a prior CRC recurrence before the baseline assessment.